Combining Surgery for Removal of Tissue and Reconstruction Benefits Patients

	Tweet

Restoring people’s health and returning them to their daily lives as soon as possible is the goal following any surgery. When a person’s ability to eat and speak is affected, as with cancer in the mouth, surgery is particularly disruptive, creating a greater challenge. A one-step surgery can remove cancerous tissue and reconstruct bone and teeth functionality immediately, positively impacting the patient’s quality of life.

A case study in the June issue of the Journal of Oral Implantology describes a one-step surgery performed on a 65-year-old woman with squamous cell carcinoma. A two-year follow-up of this patient showed the one-step procedure to be successful.

Typically, ablative surgery is first performed to remove cancerous bone and tissue. The surgery is followed by radiotherapy, and often tooth loss. Reconstructing the jaw and placing a dental implant at this point are taxing due to the side effects of radiotherapy and poor patient tolerance.

The procedure outlined in this article permitted an impression to be taken immediately after the jaw reconstruction and implant installation during the initial surgery. A rigid prosthesis was fabricated and screw-secured to the implants 48 hours later. Complementary radiotherapy began six weeks following the surgery and implant. The prosthesis was modified as necessary six months after completion of the radiotherapy.

The advantages of single surgery include a reduced risk of osteonecrosis—disease in the jawbone—which can occur with postradiation surgery. A single surgery also can decrease the need for hyperbaric oxygen therapy.

The authors emphasize that this one-step surgery is possible because it respects the concepts of basal implantology. “Absolute primary implant stability and fabrication of a highly rigid prosthesis are essential from the outset,” they conclude.

Full text of the article, “Immediate Functional Loading of an Implant-Supported Fixed Prosthesis at the Time of Ablative Surgery and Mandibular Reconstruction for Squamous Cell Carcinoma,” Journal of Oral Implantology, Volume 36, Issue 1, 2010, is available at http://www2.allenpress.com/pdf/orim-36-03-224-230_final.pdf.

About Journal of Oral Implantology
The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry.

Source:  Allen Press Publishing Services

RELATED STORIES:
Finding the Right Radiation Facility Is Critical for Cancer Patients   Molecular link between diabetes and cancer described   Exposing cancer more quickly   Brain cell migration during normal development may offer insight on how cancer cells spread   U.S. cancer drugs shortage has doctors scrambling   Innovative method to starve tumors   Women underrepresented in most cancer research   29% of Cancer Studies Report Conflict of Interest   Despite efforts, significant racial disparities in cancer therapy still exist   Potent Inhibitor Blocks Tumors from Metastasizing   Blocking “rogue gene” may stop cancer spread: study   Washington University Scientists First to Sequence Genome of Cancer Patient   Take Action to Prevent Cancer: Participate in a Prevention Study   Body Weight, Diet May Be Risk Factors for Non-Hodgkin Lymphoma   Cancer-Killing Viruses Employ Multiple Mechanisms   Discovery of a new mechanism of gene control that is associated with cancer   March is National Professional Social Work Month   Homeopathic Meds Can Coexist With Conventional Cancer Treatment   Just how safe is that steak?   Cancer society challenges Americans to get active   Combining NSAIDs with chemotherapy, radiation may improve cancer treatment   Botox Could Help Target Resistant Tumors for Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]